VERNALIS RESEARCH LIMITED
Patent Owner
Stats
- 0 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Sep 19, 2013 most recent publication
Details
- 0 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 282 Total Citation Count
- Sep 27, 1999 Earliest Filing
- 58 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
- No Technology to Display
Top Patents (by citation)
| Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
- No Recent Patents to Display
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2010/0130,515 Polymorphs and solvates of a pharmaceutical and method of makingAbandonedJul 13, 09May 27, 10[A61K, C07D, A61P]
7629349 Pyrazolo [3,4-d] pyrimidine derivatives and their use as purinergic receptor antagonistsExpiredJan 12, 06Dec 08, 09[A61K, C07D, A61P]
7598256 Pyrrolo [2,3-d] pyrimidine and their use as purinergic receptor antagonistsExpiredJan 27, 06Oct 06, 09[A61K, C07D, A61P]
2009/0181,939 Azetidinecarboxamide Derivatives And Their Use In The Treatment Of CB1 Receptor Mediated DisordersAbandonedMar 19, 09Jul 16, 09[A61K, C07D]
7547699 Tetracyclic 6 azapyrazinoindolines as 5HT2C receptor agonists for obesityExpiredApr 26, 06Jun 16, 09[A01N]
2009/0131,470 PYRAZOLE-SUBSTITUTED BENZIMIDAZOLE DERIVATIVES FOR USE IN THE TREATMENT OF CANCER AND AUTOIMMUNE DISORDERSAbandonedJun 06, 06May 21, 09[A61K, C07D, A61P]
7504522 Azetidinecarboxamide derivatives and their use in the treatment of cb1 receptor mediated disordersExpiredApr 29, 04Mar 17, 09[A61K, C07D]
2008/0153,820 Thieno(3,2-d)pyrimidines and furano(3,2-d)pyramidines and their use as purinergic receptor antagonistsAbandonedFeb 22, 08Jun 26, 08[A61K, A61P]
7384949 Thieno(3,2-d)pyrimidines and furano(3,2-d)pyrimidines and their use as purinergic receptor antagonistsExpiredJan 10, 02Jun 10, 08[C07D]
2008/0125,455 Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, Receptor ligandsAbandonedNov 21, 07May 29, 08[A61K, C07D, A61P]
2008/0114,018 Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligandsAbandonedNov 21, 07May 15, 08[A61K, A61P]
2008/0090,858 Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligandsAbandonedDec 04, 07Apr 17, 08[A61K, A61P]
7323466 Morpholine derivatives as 5HT2C receptor agonists for the treatment of obesityExpiredJan 13, 06Jan 29, 08[A61K]
7323473 Condensed indoline derivatives and their use as 5-HT, in particular 5-HT.sub.2C, receptor ligandsExpiredDec 12, 06Jan 29, 08[A61K]
7323486 Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligandsExpiredDec 12, 06Jan 29, 08[A61K]
7323487 Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligandsExpiredDec 12, 06Jan 29, 08[A61K]
7253281 Anti-obesity 1,2,3,4,10,10a-hexahydropyrazino[1,2-a]indolesExpiredJun 28, 05Aug 07, 07[C07D]
2007/0173,486 Azetidinecarboxamide derivatives and their use in the treatment of cb1 receptor mediated disordrsAbandonedApr 29, 04Jul 26, 07[A61K, C07D]
Top Inventors for This Owner
| Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.